Lucid Psycheceuticals Inc
Lucid Psycheceuticals Inc, based in Toronto, Ontario, is a biotech company inspired by psychedelics. Specializing in the development of novel therapeutic solutions for neuro and inflammatory disorders, the team at Lucid is dedicated to addressing unmet clinical challenges with a focus on small molecule drugs.
With a strong emphasis on total brain health and environmentally friendly solutions, Lucid Psycheceuticals is at the forefront of creating leading-edge therapeutics. The team consists of highly specialized science experts who are passionately committed to advancing treatments in the fields of inflammatory disorders, neurodegenerative disorders, and mental health.
Lucid's groundbreaking work includes the shortlisting of Lucid-201, a molecule proven to be effective in treating major depressive disorder and related psychiatric conditions. Additionally, through the acquisition of exclusive licenses and preclinical data, the company is actively pursuing innovative solutions for neurodegenerative disorders, showcasing their dedication to advancing the field with some of the industry's brightest minds.
Generated from the website content
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.